Your browser doesn't support javascript.
loading
Dual Effects of Cyclooxygenase Inhibitors in Combination With CD19.CAR-T Cell Immunotherapy.
Yang, Mingya; Wang, Lei; Ni, Ming; Neuber, Brigitte; Wang, Sanmei; Gong, Wenjie; Sauer, Tim; Schubert, Maria-Luisa; Hückelhoven-Krauss, Angela; Xia, Ruixiang; Ge, Jian; Kleist, Christian; Eckstein, Volker; Sellner, Leopold; Müller-Tidow, Carsten; Dreger, Peter; Schmitt, Michael; Schmitt, Anita.
Afiliación
  • Yang M; Department of Internal Medicine V, University Clinic Heidelberg, Heidelberg University, Heidelberg, Germany.
  • Wang L; Department of Hematology, the First Affiliated Hospital of Anhui Medical University, Anhui, China.
  • Ni M; Department of Internal Medicine V, University Clinic Heidelberg, Heidelberg University, Heidelberg, Germany.
  • Neuber B; Department of Internal Medicine V, University Clinic Heidelberg, Heidelberg University, Heidelberg, Germany.
  • Wang S; Department of Hematology, the Affiliated Hospital of Guizhou Medical University, Guizhou, China.
  • Gong W; Department of Internal Medicine V, University Clinic Heidelberg, Heidelberg University, Heidelberg, Germany.
  • Sauer T; Department of Internal Medicine V, University Clinic Heidelberg, Heidelberg University, Heidelberg, Germany.
  • Schubert ML; Department of Internal Medicine V, University Clinic Heidelberg, Heidelberg University, Heidelberg, Germany.
  • Hückelhoven-Krauss A; Department of Hematology, the first Affiliated Hospital of Soochow University, Suzhou, China.
  • Xia R; Department of Internal Medicine V, University Clinic Heidelberg, Heidelberg University, Heidelberg, Germany.
  • Ge J; Department of Internal Medicine V, University Clinic Heidelberg, Heidelberg University, Heidelberg, Germany.
  • Kleist C; Department of Internal Medicine V, University Clinic Heidelberg, Heidelberg University, Heidelberg, Germany.
  • Eckstein V; Department of Hematology, the First Affiliated Hospital of Anhui Medical University, Anhui, China.
  • Sellner L; Department of Hematology, the First Affiliated Hospital of Anhui Medical University, Anhui, China.
  • Müller-Tidow C; Department of Nuclear Medicine, University Clinic Heidelberg, Heidelberg University, Heidelberg, Germany.
  • Dreger P; Department of Internal Medicine V, University Clinic Heidelberg, Heidelberg University, Heidelberg, Germany.
  • Schmitt M; Department of Internal Medicine V, University Clinic Heidelberg, Heidelberg University, Heidelberg, Germany.
  • Schmitt A; Takeda Pharma Vertrieb GmbH & Co. KG, Berlin, Germany.
Front Immunol ; 12: 670088, 2021.
Article en En | MEDLINE | ID: mdl-34122428
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfocitos T / Aspirina / Inmunoterapia Adoptiva / Linfoma de Células B / Inhibidores de la Ciclooxigenasa / Antígenos CD19 / Celecoxib / Receptores Quiméricos de Antígenos Límite: Humans Idioma: En Revista: Front Immunol Año: 2021 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfocitos T / Aspirina / Inmunoterapia Adoptiva / Linfoma de Células B / Inhibidores de la Ciclooxigenasa / Antígenos CD19 / Celecoxib / Receptores Quiméricos de Antígenos Límite: Humans Idioma: En Revista: Front Immunol Año: 2021 Tipo del documento: Article País de afiliación: Alemania